Twin Tree Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-92,100
| Closed | -$5.11M | – | 1626 |
|
|
2025
Q3 | $5.11M | Sell |
92,100
-62,300
| -40% | -$3.65M | 0.02% | 753 |
|
|
2025
Q2 | $10.7M | Sell |
154,400
-443,900
| -74% | -$30.2M | 0.02% | 750 |
|
|
2025
Q1 | $41.5M | Buy |
598,300
+519,900
| +663% | +$42.9M | 0.08% | 222 |
|
|
2024
Q4 | $6.74M | Buy |
+78,400
| New | +$8.48M | 0.01% | 837 |
|
|
2024
Q2 | – | Sell |
-37,900
| Closed | -$4.87M | – | 1579 |
|
|
2024
Q1 | $4.87M | Sell |
37,900
-310,900
| -89% | -$37M | 0.01% | 818 |
|
|
2023
Q4 | $36.1M | Sell |
348,800
-333,000
| -49% | -$32.9M | 0.07% | 284 |
|
|
2023
Q3 | $62M | Buy |
+681,800
| New | +$60.1M | 0.14% | 142 |
|
|
2023
Q2 | – | Sell |
-250,600
| Closed | -$19.9M | – | 1443 |
|
|
2023
Q1 | $19.9M | Buy |
250,600
+170,800
| +214% | +$12.1M | 0.04% | 403 |
|
|
2022
Q4 | $5.4M | Sell |
79,800
-417,000
| -84% | -$24.4M | 0.01% | 724 |
|
|
2022
Q3 | $24.7M | Buy |
496,800
+379,800
| +325% | +$20.3M | 0.05% | 330 |
|
|
2022
Q2 | $6.52M | Sell |
117,000
-337,000
| -74% | -$18.7M | 0.01% | 776 |
|
|
2022
Q1 | $25.2M | Buy |
+454,000
| New | +$23.3M | 0.04% | 394 |
|
|
2020
Q3 | – | Sell |
-67,400
| Closed | -$2.21M | – | 1504 |
|
|
2020
Q2 | $2.21M | Sell |
67,400
-13,600
| -17% | -$434K | 0.01% | 862 |
|
|
2020
Q1 | $2.44M | Buy |
+81,000
| New | +$2.41M | 0.01% | 667 |
|
|
2019
Q1 | – | Sell |
-85,400
| Closed | -$1.97M | – | 1515 |
|
|
2018
Q4 | $1.97M | Buy |
+85,400
| New | +$1.9M | 0.01% | 734 |
|
|
2018
Q1 | – | Sell |
-83,000
| Closed | -$2.23M | – | 1247 |
|
|
2017
Q4 | $2.23M | Buy |
83,000
+46,000
| +124% | +$1.17M | 0.02% | 577 |
|
|
2017
Q3 | $891K | Sell |
37,000
-79,200
| -68% | -$1.79M | 0.01% | 696 |
|
|
2017
Q2 | $2.49M | Buy |
116,200
+116,000
| +58,000% | +$2.34M | 0.02% | 521 |
|
|
2017
Q1 | $3K | Buy |
+200
| New | +$3.48K | ﹤0.01% | 963 |
|
|
2015
Q3 | – | Sell |
-800
| Closed | -$22K | – | 1465 |
|
|
2015
Q2 | $22K | Sell |
800
-7,400
| -90% | -$208K | ﹤0.01% | 1251 |
|
|
2015
Q1 | $219K | Buy |
+8,200
| New | +$189K | 0.01% | 943 |
|
|
2013
Q4 | – | Sell |
-217,000
| Closed | -$3.67M | – | 991 |
|
|
2013
Q3 | $3.67M | Sell |
217,000
-131,000
| -38% | -$2.2M | 0.12% | 177 |
|
|
2013
Q2 | $5.39M | Buy |
+348,000
| New | +$5.79M | 0.21% | 74 |
|
Other funds holding NVO
F
Twin Tree Management's NVO Position: Q4 2025 in Review
Twin Tree Management sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 5,626 shares — an estimated $312K sold.
Twin Tree Management first reported a position in NVO in Q2 2013 and held it in 32 quarters. The position peaked at $25.6M in Q2 2024. 1,413 funds tracked by Wall St. Rank hold NVO as of Q4 2025.
- Twin Tree Management reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
- Twin Tree Management sold 5,626 Novo Nordisk shares in Q4 2025, an estimated $312K.
- Twin Tree Management first reported a position in Novo Nordisk in Q2 2013 and held it in 32 quarters.
- Twin Tree Management's Novo Nordisk position peaked at $25.6M in Q2 2024.
- 1,413 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.
Based on Twin Tree Management's 13F filing for Q4 2025, filed 11 Feb 2026.